摘要
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer, which is the leading cause of death in lung cancer patient. Routine treatment of NSCLC cannot effectively change the survival rate of patients, one important reason is the increased radioresistance of tumor cells after conventional radiotherapy.
基金
Key Program of National Natural Science Foundation of China(U1432248)